{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:20:07Z","timestamp":1771510807127,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"GlaxoSmithKline group of companies"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.acvd.2014.09.009","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T11:29:40Z","timestamp":1415273380000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: A pilot study"],"prefix":"10.1016","volume":"108","author":[{"given":"Ariel","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Le Heuzey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Aliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Banik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kropff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heyder","family":"Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2014.09.009_bib0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2014.09.009_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/01.CIR.98.5.479","article-title":"Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation","volume":"98","author":"Silverman","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.09.009_bib0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0002-9149(93)90884-F","article-title":"Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations","volume":"72","author":"Hwang","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0030","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehl353","volume":"27","author":"Klein","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.09.009_bib0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.CIR.0000120509.64740.DC","volume":"109","author":"Stellbrink","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.09.009_bib0040","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.09.009_bib0045","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9149(89)90264-6","article-title":"Anticoagulation for cardioversion of atrial fibrillation","volume":"63","author":"Weinberg","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0050","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"European Heart Rhythm Association","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2014.09.009_bib0055","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0060","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Task Force for Diagnosis","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.09.009_bib0065","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2014.09.009_bib0070","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2014.09.009_bib0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1378\/chest.10-1599","article-title":"Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE","volume":"140","author":"Warkentin","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2014.09.009_bib0080","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.09.009_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0090","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.09.009_bib0095","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.09.009_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00392-008-0644-y","article-title":"AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation","volume":"97","author":"Tebbe","year":"2008","journal-title":"Clin Res Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:42:08Z","timestamp":1761745328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213614002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1875213614002666"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2014.09.009","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}